Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Boffito

Correction To: CSF Inflammatory Markers and Neurocognitive Function After Addition of Maraviroc to Monotherapy Darunavir/Ritonavir in Stable HIV Patients: The CINAMMON Study

Journal of NeuroVirology

Virology

Neurology

Cellular

Molecular Neuroscience

2018

English

Tuberculosis Transmission in Botswana

Journal of Clinical Microbiology

Microbiology

2001

English

Related publications

Week 48 Efficacy and Central Nervous System Analysis of Darunavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir With Two Nucleoside Analogues

English

Correction To: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated With Darunavir

Drugs in R and D

Pharmacology

2018

English

Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients

PLoS ONE

Multidisciplinary

2019

English

Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged≥3 to <12 Years

CPT: Pharmacometrics and Systems Pharmacology

Modeling

Simulation

Cardiovascular Medicine

Pharmacology

Cardiology

2015

English

Effectiveness, Durability, and Safety of Darunavir/Ritonavir in HIV-1-infected Patients in Routine Clinical Practice in Italy: A Postauthorization Noninterventional Study

Drug Design, Development and Therapy

Drug Discovery

Pharmacology

Pharmaceutical Science

2016

English

Pharmacokinetics of Darunavir/Ritonavir and Ketoconazole Following Co-Administration in HIV-healthy Volunteers

British Journal of Clinical Pharmacology

Pharmacology

2008

English

Antiretroviral Simplification With Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile

PLoS ONE

Multidisciplinary

2012

English

Severe Dyslipidaemia After the Addition of Raltegravir to a Lopinavir/Ritonavir-Containing Regimen

English

Pharmacokinetics of Darunavir/Ritonavir in Asian HIV-1 Infected Children Aged >=7 Years

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Boffito

Correction To: CSF Inflammatory Markers and Neurocognitive Function After Addition of Maraviroc to Monotherapy Darunavir/Ritonavir in Stable HIV Patients: The CINAMMON Study

Tuberculosis Transmission in Botswana

Related publications

Week 48 Efficacy and Central Nervous System Analysis of Darunavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir With Two Nucleoside Analogues

Correction To: Evaluation of Cardiovascular Disease Risk in HIV‑1–Infected Patients Treated With Darunavir

Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients

Model-Based Once-Daily Darunavir/Ritonavir Dosing Recommendations in Pediatric HIV-1-Infected Patients Aged≥3 to <12 Years

Effectiveness, Durability, and Safety of Darunavir/Ritonavir in HIV-1-infected Patients in Routine Clinical Practice in Italy: A Postauthorization Noninterventional Study

Pharmacokinetics of Darunavir/Ritonavir and Ketoconazole Following Co-Administration in HIV-healthy Volunteers

Antiretroviral Simplification With Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile

Severe Dyslipidaemia After the Addition of Raltegravir to a Lopinavir/Ritonavir-Containing Regimen

Pharmacokinetics of Darunavir/Ritonavir in Asian HIV-1 Infected Children Aged >=7 Years